fashion -WSS

fashion

author：knowledge 2025-09-28 21:57:44 - browse：7

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： How climate

hotspot

WSS

Study: Black kids more likely to die after surgery than white kids

Trial using CRISPR to edit HIV out of cells disappoints

Multiple sclerosis has subtypes with different best treatments: study

UnitedHealth’s board chair also owns a personal investment firm

Hospital price transparency does save money, advocate argues

Overprescribed: High cost isn't America's only drug problem

focus

fashion

Wikipedia

In Memoriam: Notable people who died in 2023

How climate

Guidelines to prevent youth baseball injuries need more muscle

2023 STAT Wunderkinds: get to know the winners

In Memoriam: Notable people who died in 2023

Senate committee scrutinizes Medicare Advantage brokers

Duchenne breakthrough therapy leaves behind pioneering families

Bird flu in dairy cattle: New measures to control spread to humans

Supreme Court strikes down use of affirmative action

Eli Lilly expects to double planned employment in Boston center

explore

Oral obesity drug from Viking Therapeutics hits key early target

HHS leader on health, climate change and biopharma emissions

UnitedHealth, in a surprise, takes aim at Steward’s physician group

How climate

Scientific mystery highlights the blind spots in genomics databases

Bird flu in dairy cattle: New measures to control spread to humans

hotspot

hotspot

hotspot

explore